Turbo, great post. Agreed $75-$150 is a likely outcome. Now that we’ve passed $25 today , that makes a takeover at $75 an easy target. Then add in 2 more sets of trial results in next 8 months and it can easily rise from there. The trouble with going all the way ourselves, is the the SP will plateau and likely drop away . Many will wait on sidelines while ph3 trials are done.
Many older holders here will want to cash out and enjoy their winnings in the $75-$150 range rather than wait another 3 years at a lower price.
As with every investment there comes a time to cash out. $75-$150 looks like a great place to do that. And that poster who bought arb.006 will walk away with between 675 bags and 1,350 bags. And I would expect the his/her investment would be one for the record books in the ASX Hall of Fame. And he/she won’t be the only one with spectacular returns.
and here is some more news about Biotechs and takeovers.
https://www.biopharmadive.com/news/biotech-pharma-deals-merger-acquisitions-tracker/604262/
- Forums
- ASX - By Stock
- NEU
- Share Price
Share Price, page-8903
-
-
- There are more pages in this discussion • 4,110 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$16.57 |
Change
2.170(15.1%) |
Mkt cap ! $2.117B |
Open | High | Low | Value | Volume |
$14.85 | $16.67 | $14.60 | $24.77M | 1.544M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1500 | $16.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.57 | 1717 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 250 | 16.480 |
1 | 300 | 16.470 |
1 | 500 | 16.400 |
1 | 3 | 16.270 |
1 | 150 | 16.200 |
Price($) | Vol. | No. |
---|---|---|
16.570 | 1717 | 1 |
16.600 | 2001 | 1 |
16.620 | 2306 | 2 |
16.650 | 2000 | 1 |
16.660 | 250 | 1 |
Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online